Bristol-Myers Profit Misses Estimates as New Drugs Get Attention

Bristol-Myers Profit Misses Estimates as New Drugs Get Attention

JB Reed/Bloomberg

Sales of Bristol-Myers’s drugs that lost patent protection have largely disappeared. Plavix revenue fell to $91 million.